This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Wearable, long-term continuous heartmonitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.
Today’s video is on the subject of stroke and in particular cryptogenic strokes. It is therefore crucial to identify the cause of stroke and treat the underlying cause wherever possible. Strokes are characterised by death of brain cells as a result of disruption of blood supply to those cells.
Stroke, Ahead of Print. The bulk of the current knowledge on atrial fibrillation (AF)-associated stroke risk and benefit of oral anticoagulation derives from studies on patients with clinically diagnosed AF. How should we interpret the latest knowledge in the setting of poststroke AF screening and prevention?
About a million possible cases of atrial fibrillation, a known risk for stroke, go undetected in Japan. Founded in 2019, Cardio Intelligence develops a range of AI-powered solutions for continuous heartmonitoring called SmartRobin AI. A local startup is introducing an innovative AI targeting this growing danger.
The study is the largest and most robust of its kind to date, examining 102,475 Hello Heart users with high BP (hypertension) between January 2018 and December 2022. Users were equipped with Hello Heart’s connected heart health monitor and mobile app with digital coaching.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content